Cargando…
Sintilimab-induced autoimmune diabetes: A case report and review of the literature
BACKGROUND: With the widespread application of immune checkpoint inhibitor (ICI) therapy, the number of immune-related adverse effects (irAEs) has increased over the years. Autoimmune diabetes mellitus (DM) is a rare irAEs of ICIs and can be troublesome and life threatening. CASE SUMMARY: We report...
Autores principales: | Yang, Jing, Wang, Ying, Tong, Xiang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855200/ https://www.ncbi.nlm.nih.gov/pubmed/35211559 http://dx.doi.org/10.12998/wjcc.v10.i4.1263 |
Ejemplares similares
-
Sintilimab-Induced Diabetic Ketoacidosis in a Patient with Radiation and Multichemorefractory Penile Cancer: A Case Report and Literature Review
por: Lv, Chuan, et al.
Publicado: (2022) -
Sintilimab: Pneumonitis: case report
Publicado: (2021) -
Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review
por: Liu, Xin, et al.
Publicado: (2023) -
Sintilimab-related diabetes mellitus and psoriasis: A case report and literature review
por: Huang, Wenying, et al.
Publicado: (2023) -
Adverse skin reactions induced by sintilimab in advanced lung squamous carcinoma: a case report and review of the literature
por: Yan, Juan, et al.
Publicado: (2022)